ISPUB.com / IJE/7/2/3667
  • Author/Editor Login
  • Registration
  • Facebook
  • Google Plus

ISPUB.com

Internet
Scientific
Publications

  • Home
  • Journals
  • Latest Articles
  • Disclaimers
  • Article Submissions
  • Contact
  • Help
  • The Internet Journal of Epidemiology
  • Volume 7
  • Number 2

Original Article

Hospital Charges and Comorbidities of Obese and Morbidly Obese Patients

W Hlaing, S Kim, D Davalos

Keywords

comorbidities, hospital charges, icd-9, morbid obesity, obesity, raceethnicity

Citation

W Hlaing, S Kim, D Davalos. Hospital Charges and Comorbidities of Obese and Morbidly Obese Patients. The Internet Journal of Epidemiology. 2008 Volume 7 Number 2.

Abstract

To examine the variations in average hospital charges and to describe comorbidities between non-obese, obese, and morbidly obese, a retrospective analysis of 2005 inpatient data from the Florida Agency for Health Care Administration (AHCA) was performed. Of all hospitalizations (N=2,534,641) in Florida during 2005, 94.9%, 3.3%, and 1.8% belonged to non-obese, obese, and morbidly obese patients, respectively. Socio-demographic (e.g., race/ethnicity, health insurance) and hospital characteristics (e.g., length of stay or LOS) differed significantly in three groups. Also, case mix, age, sex, race/ethnicity, LOS, and health insurance-adjusted mean hospital charges (US $) were significantly different among non-obese (15,021), obese (19,550), and morbidly obese groups (22,192) (p < .01). The most common reason for hospitalization was coronary atherosclerosis among non-obese and obese patients while it was congestive heart failure among morbidly obese patients. Hospital charges increased as weight increased among Florida inpatients, thus, economicconsequences of obesity should be further explored.

 

Note: Work originated when W.M. Hlaing and D.M. Davalos were in the department of Epidemiology and Biostatistics at Florida International University.

Introduction

Next to tobacco use, obesity is the second leading cause of preventable mortality and a major cause of morbidity and disability in the United States (US). 1-6 The proportion of overweight/ obesity in the US has risen in the last two decades 7-13 and recent national studies have reported that 64.5% and 30.5% of Americans are overweight, and obese, respectively. 6-7, 9-11, 14-15

Rising obesity and its associated comorbidities result in deleterious effects on health status 7, 9-11, 13-23 and a significant increase in health burdens. 2, 6-7, 19, 24 Excess cost attributable to overweight and obesity was reported to be approximately $92.6 billion dollars, comprising between 6 - 10% of the total health care expenditure of the US. 7-8, 10-11, 15, 19, 25-26 Obese individuals had 36% higher annual health care costs than non-obese individuals. 7, 11, 14

While there were numerous national studies on obesity, reports on obesity in Florida had primarily been descriptive in nature and restricted to the non-hospitalized population. In 2005, about 37.9% of Florida adults were overweight and 22.8% were obese. 27-30 Hospital resource use among obese patients of Florida has not been reported. The purposes of the study were (1) to compare the demographic and clinical characteristic differences including adjusted mean hospital length of stay (LOS) and charges between non-obese, obese, and morbidly obese patients and (2) to describe the frequencies of primary reasons for hospitalization (primary diagnosis) and comorbidities (secondary diagnosis) separately in these three groups.

Method

Inpatient data from the Florida Agency for Health Care Administration (AHCA) were obtained and retrospectively examined. The dataset contained demographic and clinical information of all patients admitted in Florida hospitals during 2005. Hospitals included all acute care and short-term psychiatric hospitals in Florida. 31 Data contained no personal identifiers. The study was approved by the Institutional Review Board (IRB) at Florida International University.

Of all patients (N=2,534,641) hospitalized in 2005 in Florida, the sample was further categorized using the International Classification of Diseases, Ninth Edition (ICD-9) diagnosis codes. Those with a primary or secondary diagnosis of obese (ICD-9 code: 27800) and morbidly obese (ICD-9 code: 27801) were grouped. Due to the small sample size (< 1%), overweight (ICD-9 code: 27802) patients were combined with the remaining patients and labeled as non-obese.

Socio-demographic information included in the analyses were age (years), sex, race/ethnicity, and insurance status. Age was treated as both continuous and dichotomous variables. Using the median age (55 years), it was dichotomized as < 55 and > 55 years of age. Sex (male and female) and race/ethnicity (whites, blacks, Hispanics, and others) were categorized. The original insurance variable was recoded into four groups as follows: 1) Commercial (Health Maintenance Organizations (HMO) and Preferred Provider Organizations (PPO)), 2) Federal or Medicare which included Medicare and other major federal carriers such as the Civilian Health and Medical Program of the Uniformed Services (CHAMPUS) and Veterans Administration (VA), 3) State/Medicaid which included Medicaid and other state payers such as Worker’s Compensation , and 4) Others included underinsured, charity, and uninsured. In addition, type of admission, discharge status, LOS (days), and hospital charges (US $) were examined. Hospital charges or total gross charges included the total bill of services rendered in the hospital and did not include professional (i.e., physician) fees. 31 Patients who required immediate medical intervention were coded as an emergency admission while patients with non-life threatening conditions were coded as a non-emergency admission. Those admitted for obstetric reason (e.g. childbirth) were coded separately from emergency and non-emergency admission. 31 Discharge status was grouped into four categories; 1) discharged home, 2) discharged to another facility (hospital, skilled nursing facility, home healthcare facility etc), 3) died in hospital, and 4) referred to hospice care. Due to the skewed distribution of LOS and hospital charges, the log-transformed scales were used in the model. The median LOS (3 days) and hospital charges (US $ 15,945) were used to categorize each variable into two or three groups (i.e., < 3, =3, and > 3 days or < 3 and > 3 days of LOS; < US $ 15,945 and > US $ 15,945 of hospital charges). The case mix index (CMI) for hospitals was also included in the obesity-hospital charges model. The AHCA calculated the CMI for all hospitals included in the 2005 database, as guided by the Ingenix Diagnosis Related Group (DRG) Expert. The CMI is defined as the average diagnosis-related group (DRG) weight for all of a hospital’s Medicare volume and it can be used to adjust the average cost per patient or per day for a given hospital relative to the adjusted average cost for other hospitals. 32 The CMI was treated as a continuous variable in this study. In addition, we described the most common reasons for hospital admission (i.e., primary diagnosis) and the most frequently diagnosed secondary comorbidities for non-obese, obese, and morbidly obese patients.

The Statistical Analysis System (SAS®) for Windows, Release 9.1 (The SAS Institute, Cary, NC) was used for all analyses. The differences in frequencies of clinical and socio-demographic characteristics between three groups (non-obese, obese, and morbidly obese) were evaluated using chi-square ( 2 ) tests. Group comparisons of adjusted LOS and hospital charges were made using multiple regression models (PROC GLM) with multiple comparison tests. Because the log-scales of LOS and hospital charges were used in the models, their respective adjusted geometric means and the corresponding 95% confidence intervals (CI) were computed. Further, proportions of the most frequently diagnosed primary and secondary diagnoses were described and ranked between three groups.

Results

Of 2,534,641 hospitalizations in Florida in 2005, 94.9%, 3.3% and 1.8% of records belonged to non-obese, obese, and morbidly obese patients, respectively (Table I). About 66% of patients were whites with approximately equal proportions of blacks and Hispanics. Most patients had Federal or Medicare (43.4%) as their primary payer. About 8.4% were either underinsured or uninsured.

Figure 1
Table I: Characteristics of patients hospitalized in Florida, 2005 (N = 2,534,641)

There were more females than males in all three groups (non-obese, obese, and morbidly obese) (Table II). While most patients were whites in all groups, there were more blacks than Hispanics in both obese and morbidly obese groups. Over half of the patients were admitted for emergency reasons regardless of their weight status. All patients admitted for obstetric reasons (i.e., newborn delivery) belonged to the non-obese group (data not shown). While the majority was discharged home in all groups, the proportion of those discharged to another care facility was highest among the morbidly obese group. A higher proportion of morbidly obese (0.9%) patients died in hospitals compared with obese (0.5%) patients. About 8.4%, 8.5%, and 9.5% of non-obese, obese, and morbidly obese patients, respectively, were underinsured or uninsured.

Figure 2
Table II: Demographic and clinical characteristics of patients by weight-status (N = 2,534,641)

Obese and morbidly obese patients were older than their non-obese counterparts. The mean and standard error (± SE) for age (years) was 50.2 ± 0.02 (non-obese), 55.4 ± 0.1 (obese), and 52.2 ± 0.1 (morbidly obese). The median age (years) for each group was 55.0 (non-obese), 56.0 (obese) and 53.0 (morbidly obese) (data not shown). The average unadjusted LOS (days) was significantly different between all three pairs: non-obese (3.3), obese (3.2), and morbidly obese (3.6) (Table III). Initially, four models were fitted to derive adjusted LOS controlling for (1) age alone; (2) age, and race/ethnicity; (3) age, race/ethnicity, and sex; and (4) age, race/ethnicity, sex, and health insurance. Likewise, seven models were fitted initially to derive adjusted hospital charges controlling for (1) case mix alone; (2) case mix, and age; (3) case mix, age, and race/ethnicity; (4) case mix, age, race/ethnicity, and sex; (5) case mix, age, race/ethnicity, sex, and insurance status; (6) case mix, age, race/ethnicity, sex, insurance status, and LOS; and (7) all variables in model 6 without the case mix. The best model for each outcome (LOS and hospital charges) was selected and presented in Table III. Age, race/ethnicity, sex, and insurance status-adjusted LOS were different significantly between non-obese (3.3), obese (3.1), and morbidly obese (3.6) patients (p < .01 between all three pairs). There was a positive relationship between weight-status and unadjusted mean hospital charges (US $). Similarly, when mean hospital charges were adjusted for case mix, age, race/ethnicity, sex, health insurance and LOS, the charges (US $) were the lowest among non-obese (15,021) patients followed by obese (19,550) and morbidly obese (22,192) patients. All three pairs were significantly different at alpha < .01 level.

Figure 3
Table III: Crude and adjusted hospital length of stay and charges by weight-status (N = 2,534,641)

Because primary diagnoses relating to obstetric reasons (e.g. childbirth) were found among the non-obese group only, these reasons were not included in the primary and secondary diagnosis results (Table IV). The most common primary diagnosis was coronary atherosclerosis in non-obese (9.5%) and obese (25.5%) groups while it was unspecified congestive heart failure in morbidly obese (23.8%) group (Table IV). The most common secondary diagnosis was unspecified essential hypertension in all three groups (Table V). About 23.6% (non-obese), 18.8% (obese), and 28.1% (morbidly obese) of patients had essential hypertension. The second most common diagnosis in the non-obese group was unspecified hyperlipidemia (8.3%). However, Type 2 diabetes mellitus was the second most common diagnosis in the obese (9.3%) and the morbidly obese (16.5%) groups. The third common diagnosis was Type 2 diabetes mellitus for non-obese patients and unspecified hyperlipidemia for obese and morbidly obese patients.

Figure 4
Table IV: The most common primary reasons for hospitalization by weight-status

Figure 5
Table V: The most common secondary diagnoses by weight-status

Discussion

Two salient findings from this study were related to the prevalence of obesity. During 1999-2004, the prevalence of obesity in the US increased. 33 The reason was due to a significant increase of obesity among men while obesity among women leveled off during this period. 20, 33 According to the 2005 Behavioral Risk Factor Surveillance Survey (BRFSS) data, 37.9% of adults were overweight and 22.8% were obese in Florida. 28 In the same year, among hospitalized patients of our study, the prevalence of overweight was extremely low (< 1%). This may be due to the facts that the ICD-9 code for overweight was recently added and physicians often underestimated the overweight status of their patients. 34-35 It was shown that about a quarter of overweight patients were thought to be of normal weight by their doctors. 34 The prevalence of obesity in our study was 3.3% while it was 22.8% 28 among general population of Florida in 2005. The reason for the divergent proportions may be that the remainder obese populations in Florida did not need hospital care or received care in non-hospital settings or did not have access to medical care or were not diagnosed accurately due to the use of ICD-9 code.

In our study, most (66.4%) patients were whites with almost equal proportions of blacks (15.5%) and Hispanics (15.4%). Race/ethnic breakdown of Florida’s population in 2005 was 62.3% whites, 15.5 % blacks, and 19.7 % Hispanics. 28 Therefore, the race/ethnic proportions of general and hospitalized populations in Florida were similar except that there were more whites and less Hispanics among the hospitalized population. This could be due to the reason that Hispanics were more likely to lack access to health care than persons of other race/ethnic groups. 36

The obesity prevalence among blacks in our study deserves discussion. Several studies in the US have reported that increases in obesity prevalence and related health consequences disproportionately affect minority groups such as blacks and Hispanics. 1, 6, 8, 37 The National Center for Health Statistics (NCHS) indicated that approximately 45.0% of black and 36.8% of Hispanic adults were obese. 38 In our study, while the majority was whites in all three weight-status groups, there were more blacks than Hispanics in both obese and morbidly obese groups. Our finding mirrored the US obesity prevalence which indicated blacks were disproportionately affected 20 with 6% of black women compared to 2.8% of all US women were reported to be morbidly obese. 39-40 Evidence suggested that the strikingly high obesity risk among blacks responded to social and cultural standards about diet, physical activity, sedentary behavior, and perception of body size. 1, 40-42 Additionally, analysis of the National Health and Nutrition Examination Survey (NHANES) III data indicated that blacks were characterized by relatively low levels of physical activity and high levels of inactivity during leisure time. 40, 42 Black women reported greater body satisfaction than Hispanic women 40 and black women considered overweight bodies more attractive. 1, 43

Other interesting findings about hospitalized patients of Florida were linked to differences in the characteristics, mean hospital charges and comorbidities between groups. However, it should be noted that these findings are discussed based on the overall result (i.e., global p value) of the general association between obesity and related characteristic. First, as indicated in the general association between obesity and discharge status result (p < .01), a higher proportion of morbidly obese (0.9%) patients died in hospitals compared with obese (0.5%) patients. Similarly, previous studies indicated that obesity was associated with more complicated care, reduced life expectancy and higher mortality rates. 9-11, 14 A dose-response relationship between high body mass index (BMI as a measure of obesity) and increased poor health outcomes and mortality had also been described. 6, 44-55 Second, morbidly obese patients in our sample were likely to be either underinsured or uninsured, and were more likely to be discharged to other care facilities compared with other groups. Runge (2007) 46 indicated that while a lack of economic opportunity increased the chance of becoming obese, obesity also hindered an individual’s economic opportunity. Previous studies demonstrated that uninsured adults faced severe negative health consequences due to lack of preventive and treatment services for chronic diseases. 46-48 Additionally, unemployed and underprivileged individuals were more likely to be obese and diabetic, 26, thus, their health care cost tended to be higher compared with their employed and privileged counterparts. 14 Third, a positive association was found between adjusted mean hospital charges and weight status; hospital charges increased with increased level of obesity. This association was found after adjusting for individual (e.g. age, insurance status, severity of disease as defined by length of stay), and hospital (e.g. case mix index) level characteristics. Previous studies showed a strong association between BMI and higher health care costs 6, 10-11 with a 25%, 50% and 100% increase in costs for patient with a BMI of 30 to 35, 35 to 40, and over 40, respectively. 7-8, 11 Evidence suggested that a higher obesity-related health care cost was a function of significantly higher use of health care resources, medical care and prescription drugs. Medical conditions linked to obesity were more frequent among severely obese individuals than moderately obese individuals. 6-7, 11, 14, 19 Increment of charges and utilization rates were a result of treating important obesity associated comorbidities such as hypertension, hyperlipidemia, Type 2 diabetes mellitus, coronary artery disease, and stroke which accounted for almost 85% of the economic burden of obesity. 6, 8, 11 Fourth, findings from our study showed that the most common primary diagnosis was coronary atherosclerosis among non-obese and obese patients while it was unspecified congestive heart failure (CHF) among morbidly obese patients. Correspondingly, national data from the American Heart Association (AHA) recognized atherosclerotic coronary disease as a major source of morbidity and the leading cause of death in the US. 49 Numerous studies indicated that obesity associated health problems were more frequent among morbidly obese than obese individuals. 7-10, 15 Consequences of obesity included cardiovascular disease, disability and death in several studies. 7, 10-11, 14-17, 19, 50-51 Also, morbid obesity proved to be a known risk factor for CHF. 4, 52-53 The Framingham Study data showed an increased risk form men (5%) and women (7%) to develop CHF with each unit increment of BMI. 54 The most common secondary diagnosis in our study was unspecified essential hypertension in all three groups. While the second most common comorbidity was unspecified hyperlipidemia in non-obese patients, it was Type 2 diabetes mellitus in both obese and morbidly obese patients. Likewise, previous studies indicated that hypertension was the chief medical problem linked to obesity. 7, 9-11, 14, 16-17, 38, 55 Similarly, the Behavioral Risk Factor Surveillance System (BRFSS) data established obesity as a risk factor for the development of Type 2 diabetes, estimating that for every kilogram increase in weight, the prevalence of diabetes increased by 9%. 56 Moreover, among people diagnosed with Type 2 diabetes, 67% were overweight (BMI ≥27) and 46% were obese (BMI ≥30). 56

The limitations associated with our study are outlined below. The Florida AHCA dataset used for this study was specifically collected for administrative purposes. Consequently, a number of important indicators useful for clinical (e.g. chronicity of obese and morbidly obese status) and epidemiologic (e.g. continuous measures of patients’ weight, height, and BMI) studies were not available. Because unique patient identifiers (e.g. social security number) of records were not released for public use, the sample size in our study corresponded to the number of records. Also, those patients hospitalized outside of Florida and those who died while outside of Florida were not included in the data.

Conclusion

The study revealed important information about the characteristic differences between hospitalized patients who were non-obese, obese, and morbidly obese in Florida. The adjusted length of stay (LOS) between non-obese, obese, and morbidly obese patients was significantly but not substantially (0.1 to 0.5 day) different. When multiple factors including LOS were adjusted, hospital charges were significantly and substantially different among the three groups with the highest charges among the morbidly obese. Thus, the study further emphasized the high burden of obesity in Florida with a higher use of hospital resources related to higher degrees of obesity. With a high prevalence and severity of obesity among populations across the US, Florida health care providers should be prepared to deliver appropriate preventive programs and health care services for obese individuals. Obesity prevention/treatment and outcome research involving racial/ethnic minorities and socio-economically disadvantaged groups of Florida are also needed. The study underscored the need for obesity prevention initiatives in Florida.

References

1. Blixen CE, Singh A, Thacker H. Values and Beliefs about Obesity and Weight Reduction among African American and Caucasian Women. J of Transcult Nurs 2006;17:290-297.
2. Flegal K, Carroll M, Ogden C, Johnson C. Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288:1723-1727.
3. Flegal K, Williamson DF, Pamuk ER, Rosenberg HM. The burden of obesity: Estimating deaths attributable to obesity in the United States. Am J Public Health 2004;94:1486-1489.
4. Gallagher MJ, Franklin BA, Ehrman JK, Keteyian SJ, Brawner CA, deJong AT, McCullough PA. Comparative impact of morbid obesity vs. heart failure on cardiorespiratory fitness. Chest 2005;127:2197-2203.
5. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual Causes of Death in the United States, 2000. JAMA 2004;291:1238-1245.
6. Wee CC, Phillips RS, Legedza AT, Davis RB, Soukup JR, Colditz GA, Hamel MB. Health Care Expenditures Associated With Overweight and Obesity Among US Adults: Importance of Age and Race. Am J Public Health 2005;95:159–165.
7. Andreyeva T, Sturm R, Ringel JS. Moderate and Severe Obesity Have Large Differences in Health Care Costs. Obes Res 2004;12:1936-1943.
8. Fontaine KR, Bartlett SJ. Access and Use of Medical Care among Obese Persons. Obes Res 2000;8(5): 403-406.
9. Malnick SD, Knobler H. The medical complications of obesity. QJM : An Int J Med 2006;99:565-579.
10. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss. An Update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006; 113:898-918.
11. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health Services Use and Health Care Costs of Obese and Nonobese Individuals. Arch Intern Med 2004;164:2135-2140.
12. Wang YC, Colditz GA, Kuntz KM. Forecasting the Obesity Epidemic in the Aging U.S. Population. Obesity 2007;15(11):2855-2865.
13. World Health Organization (WHO). Obesity: Preventing and managing the global epidemic. Report of a WHO consultation, 2000. World Health Org Tech Rep Ser 894, i-xii.
14. Bertakis KD, Azari R. Obesity and the Use of Health Care Services. Obes Res 2005;13(2):372-379.
15. Murphy NF, MacIntyre K, Stewart S, Hart CL, Hole D, McMurray JJ. Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (The Renfrew–Paisley study). Eur Heart J 2006; 27:96-106.
16. Avelar E, Cloward TV, Walker JM, Farney RJ, Strong M, Pendleton RC, Segerson N, Adams TD, Gress RE, Hunt SC, Litwin SE. Left Ventricular Hypertrophy in Severe Obesity Interactions Among Blood Pressure, Nocturnal Hypoxemia, and Body Mass. Hypertension 2007;49:34-38.
17. De Simone G. Morbid Obesity and Left Ventricular Geometry. Hypertension 2007;49:7-9.
18. Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: A call to action from the American diabetes association and the American heart association. Circulation 2006;113(25):2943-2946.
19. Hart CL, Hole DJ, Lawlor DA, Smith GD. Obesity and use of acute hospital services in participants of the Renfrew/Paisley study. J Public Health 2006;29 (1):53–56.
20. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among U.S. children, adolescents, and adults, 1999–2002. JAMA 2004;291:2847-2850.
21. Okosun IS, Choi S, Matamoros T, Dever GE. Obesity is associated with reduced self-rated general health status: Evidence from a representative sample of white, black, and Hispanic Americans. Prev Med 2001;32(5):429-436.
22. National task force on the prevention and treatment of obesity. Overweight, obesity, and health risk. Arch Intern Med 2000;160(7):898-904.
23. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, Inactivity, and the Prevalence of Diabetes and Diabetes-Related Cardiovascular Comorbidities in the U.S., 2000–2002. Diabetes Care 2005;28:1599-1603.
24. Heithoff KA, Cuffel BJ, Kennedy S, Peters J. The association between body mass and health care expenditures. Clin Ther 1997;19(4):811-820.
25. Finkelstein EA, Fiebelkorn IC, Wang G. National medical spending attributable to overweight and obesity: How much, and who's paying (Project Hope)? Health Aff 2003;Suppl Web Exclusives, W3-219-226.
26. Zizza C, Herring AH, Stevens J, Popkin BM. Length of Hospital Stays among Obese Individuals. Am J Public Health 2004;94:1587-1591.
27. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System- United States, 2005. Available at: http://unitedhealthfoundation.net/shr2005/components/obesity.html. (Available date: April 1, 2008).
28. Florida Department of Health, 2006. Current Trends and Statistics: Prevalence of Obesity in the State of Florida. Available at:http://www.doh.state.fl.us/Family/obesity/stats.html. (Available date: February 01, 2008).
29. Trust for America's Health (TFAH). F as in Fat: How Obesity Policies are Failing in America 2005. Washington, D.C., Trust for America’s Health, October 2004. Available at: www.healthyamericans.org. (Available date: January 28, 2008).
30. Trust for America's Health (TFAH). Florida Ranks 43rd in Nation for Obesity, New Report Finds State and Federal Obesity Policies are Failing. Healthy Americans Reports, 2007. Available at: http://healthyamericans.org/reports/obesity/release.php?StateID=FL. (Available date: January 28, 2008).
31. Agency for Health Care Administration (AHCA), 2007. Florida Center for Health Information and Policy Analysis. Data Catalog. Available at: http://www.floridahealthfinder.gov/Researchers/OrderData/documents/Data_catalog%20August%202007.doc. (Available date: February 1, 2008).
32. Ingenix. Ingenix 2008 Diagnosis Related Group (DRG) Desk Reference: A comprehensive guidebook to the DRG Classification System, 2007; Ingenix.
33. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of Overweight and Obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
34. Frühbeck, G. Letters: Preventing obesity. Doctors underestimate obesity. BMJ 2003;326:102.
35. Halenar, B. ICD-9: What's changed? Med Econ 2005; Oct 7. Available at: http://www.memag.com/memag/article/articleDetail.jsp?id=182798. (Available date: April 9, 2008).
36. Centers for Disease Control and Prevention. Office of Media Relations, 2003. Access to Health Care and Prevention Services among Hispanics and Non-Hispanics. Available at: http://www.cdc.gov/od/oc/Media/presskits/hhd/hlthcare.htm. (Available date: May 1, 2008).
37. Borders TF, Rohrer JE, Cardarelli KM. Gender-specific disparities in obesity. J Community Health 2006 Feb;31(1):57-68.
38. National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention, 2006. Obesity Still a Major Problem. U.S. Department of Health and Human Services. Available at: http://www.cdc.gov/nccdphp/dnpa/obesity/trend/index.htm. (Available date: February 15, 2008).
39. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002;288:1758-1761.
40. Sanchez-Johnsen L, Fitzgibbon ML, Martinovich Z, Stolley MR, Dyer AR, Van Horn L. Ethnic Differences in Correlates of Obesity between Latin-American and Black Women. Obes Res 2004;12:652-660.
41. Cummins S, Macintyre S. Food environments and obesity: neighborhood of nation? Int J Epidemiol 2006;35:100-104.
42. Kumanyika SK, Gary TL, Lancaster KJ, Samuel-Hodge CD, Banks-Wallace J, Beech BM, Hughes-Halbert C, Karanja N, Odoms-Young AM, Prewitt TE, Whitt-Glover MC. Achieving Healthy Weight in African-American Communities: Research Perspectives and Priorities. Obes Res 2005;13:2037-2047.
43. Flynn KJ, Fitzgibbon M. Body images and obesity risk among black females: A review of the literature. Ann Behav Med 1998;20:13-24.
44. McTigue K, Larson JC, Valoski A, Burke G, Kotchen J, Lewis CE, Stefanick ML, Van Horn L, Kuller L. Mortality and Cardiac and Vascular Outcomes in Extremely Obese Women. JAMA 2006;296:79-86.
45. Sjostrom LV. Mortality of severely obese subjects. Am J Clin Nutr 1992;55:516S-523S.
46. Runge CF. Economic Consequences of the Obese. Diabetes 2007;56:2668-2672.
47. Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM. Unmet health needs of uninsured adults in the United States. JAMA 2000;284:2061-2069.
48. DeVoe JE, Fryer GE, Phillips R, Green L. Receipt of preventive care among adults: insurance status and usual source of care. Am J Public Health 2003; 93:786-791.
49. American Heart Association. 2008. Heart and Stroke Statistical Update. Dallas, TX: American Heart Association, 2000. Available at: http://www.americanheart.org/downloadable/heart/1200078608862HS_Stats%202008.final.pdf. (Available date: April 15, 2008).
50. Centers for Disease Control and Prevention. Prevalence of overweight and obesity among adults with diagnosed diabetes- United States, 1988–1994 and 1999–2002. MMWR 2004; 53:1066-1068.
51. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ, Holmes DR Jr. Secular trends in coronary atherosclerosis--analysis in patients with valvular regurgitation. N Engl J Med 1996 Aug 1;335(5):316-22.
52. Alpert MA, Lambert CR, Panayiotou H, Terry BE, Cohen MV, Massey CV, Hashimi MW, Mukerji V. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995;76:1194-1197.
53. Gustafsson F, Kragelund CB, Torp-Pedersen C, Seibæk C, Burchardt H, Akkan D, Thune JJ, Køber L for the DIAMOND study group. Effect of obesity and being overweight on long-term mortality in congestive heart failure: influence of left ventricular systolic function. Eur Heart J Jan 2005;26:58-64.
54. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS. Obesity and the risk of heart failure. New Engl J Med 2002; 347:305-313.
55. National Hospital Discharge Survey (NHDS). National Center for health Statistics. Center of Diseases Control and Prevention, 2003. Available at: http://www.tdrdata.com/HIP/hip_samples.aspx. (Available date: April 15, 2008).
56. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS. Diabetes trends in the U.S.: 1990–1998. Diabetes Care 2000;23:1278-1283.

Author Information

WayWay M. Hlaing, MBBS, MS, PhD
Division of Pediatric Research, Department of Pediatrics, Batchelor Children’s Research Institute # 513, Leonard M. Miller School of Medicine, University of Miami

Sunny Kim, PhD
Department of Epidemiology & Biostatistics, Stempel School of Public Health, Florida International University

Diana M. Davalos, MD, MPH
Clinical Research Coordinator, Dermatology Associates & Research

Download PDF

Your free access to ISPUB is funded by the following advertisements:

 

BACK TO TOP
  • Facebook
  • Google Plus

© 2013 Internet Scientific Publications, LLC. All rights reserved.    UBM Medica Network Privacy Policy